<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Vet. Sci.</journal-id>
<journal-title>Frontiers in Veterinary Science</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Vet. Sci.</abbrev-journal-title>
<issn pub-type="epub">2297-1769</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fvets.2024.1360878</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Veterinary Science</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Sodium butyrate impedes the lymphoma caused by Marek&#x2019;s disease virus via regulating the mitochondrial apoptosis pathway</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Qiaoer</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Zhou</surname>
<given-names>Jun</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Yang</surname>
<given-names>Fan</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zheng</surname>
<given-names>Congsen</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Meiting</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chang</surname>
<given-names>Chuanzhe</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cai</surname>
<given-names>Shikai</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wen</surname>
<given-names>Feng</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1066918/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Nina</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1091468/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Yanfeng</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Qin</surname>
<given-names>Limei</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2612460/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>School of Life Science and Engineering, Foshan University</institution>, <addr-line>Foshan</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Guangdong Provincial Key Laboratory of Animal Molecular Design and Precise Breeding, Foshan University</institution>, <addr-line>Foshan</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0002"><p>Edited by: Marxa L. Figueiredo, Purdue University, United States</p></fn>
<fn fn-type="edited-by" id="fn0003"><p>Reviewed by: Kishor Pant, University of Minnesota Twin Cities, United States</p>
<p>Daryoush Babazadeh, Shiraz University, Iran</p></fn>
<corresp id="c001">&#x002A;Correspondence: Limei Qin, <email>qlm@fosu.edu.cn</email></corresp>
<fn fn-type="equal" id="fn0001"><p><sup>&#x2020;</sup>These authors have contributed equally to this work</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>02</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>11</volume>
<elocation-id>1360878</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>12</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>02</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 Lin, Zhou, Yang, Zheng, Chen, Chang, Cai, Wen, Wang, Chen and Qin.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Lin, Zhou, Yang, Zheng, Chen, Chang, Cai, Wen, Wang, Chen and Qin</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Sodium butyrate (NaB) has garnered attention in recent years for its ability to impede the malignant progression of tumors. In order to explore the potential inhibitory effects of NaB on the replication of Marek&#x2019;s disease virus (MDV) and subsequent lymphoma formation, newly hatched chickens were infected with the vvMDV Md5 strain and administered NaB prior to (prevention group) or following (treatment group) Md5 inoculation. The results revealed that NaB played a pivotal role in diminishing both the incidence and fatality rates in chickens afflicted with Md5 infection. Notably, NaB exhibited a remarkable capacity to inhibit the expression of MDV immediate early genes, i.e., <italic>ICP4</italic> and <italic>ICP27</italic>, thus attenuating tumorigenesis in the chicken spleen. To further elucidate the mechanism of NaB on lymphoma cells, MDV bearing lymphoma cells, i.e., MSB-1 were exposed to NaB for 24&#x2009;h prior to various experimental tests. The results revealed that NaB effectively hindered the proliferation, migration, and colony formation of MSB-1 cells. Furthermore, NaB demonstrated the ability to modulate the key molecules in mitochondrial apoptosis pathway. Taken together, these findings reveal that NaB can impede the lymphoma caused by MDV via regulating the mitochondrial apoptosis pathway, both <italic>in vitro</italic> and <italic>in vivo</italic>. These results suggest that the utilization of NaB warrants serious consideration as a promising approach for the prevention of MDV.</p>
</abstract>
<kwd-group>
<kwd>sodium butyrate</kwd>
<kwd>lymphoma</kwd>
<kwd>apoptosis</kwd>
<kwd>mitochondrion</kwd>
<kwd>MDV</kwd>
<kwd>latency</kwd>
<kwd><italic>ICP4</italic></kwd>
</kwd-group>
<counts>
<fig-count count="11"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="65"/>
<page-count count="15"/>
<word-count count="8297"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Oncology in Veterinary Medicine</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<label>1</label>
<title>Introduction</title>
<p>Marek&#x2019;s Disease (MD) is a highly contagious lymphoproliferative and immunosuppressive disease caused by the oncogenic &#x03B1;-herpesvirus Marek&#x2019;s Disease Virus (MDV) (<xref ref-type="bibr" rid="ref1">1</xref>). MD has caused significant economic losses to the global poultry industry over the past few decades. Although the use of vaccines has greatly reduced the incidence of MD, there has been a recent increase in reports of MD worldwide in the last few years (<xref ref-type="bibr" rid="ref2 ref3 ref4 ref5 ref6">2&#x2013;6</xref>). The disease is primarily transmitted through airborne dissemination of dust particles containing infected chicken feather follicle epithelial cells, which are inhaled by susceptible birds (<xref ref-type="bibr" rid="ref7">7</xref>). In addition to causing mortality and reduced productivity in chickens, MD also induces immunosuppression in the host, making them susceptible to secondary infections by other pathogens (<xref ref-type="bibr" rid="ref8">8</xref>).</p>
<p>MDV, a tumorigenic herpesvirus, is frequently utilized as a tool to investigate the pathogenesis of viral infections (<xref ref-type="bibr" rid="ref9">9</xref>). Initiation of the viral process occurs when avian hosts respire airborne particles laden with viral entities, leading to the establishment of latency within CD4+&#x2009;T cells in chickens and subsequent transformation (<xref ref-type="bibr" rid="ref10">10</xref>). The successful establishment of latency confers the ability to perpetuate the viral genome, and the capacity to establish enduring latency within the host, with intermittent reactivation, represents a pivotal aspect of the virus&#x2019; survival strategy (<xref ref-type="bibr" rid="ref11">11</xref>). Viral latency culminates in the infection of a substantial population of CD4+ T lymphocytes, while reactivation engenders the conversion of T lymphocytes into lymphoma cells that disseminate across various organs within the body (<xref ref-type="bibr" rid="ref12">12</xref>). Consequently, the phases of latent infection and reactivation assume critical roles as pivotal junctures in the prevention and management of early MDV infection. The involvement of <italic>ICP4</italic> and <italic>ICP27</italic> in the progression of latent MDV infection contributes to the establishment and sustenance of latency. <italic>ICP4</italic> assumes a pivotal function in modulating the cascade of gene expression that governs viral infection. It engenders the transcription of MDV-specific genes in conjunction with multiple transcription factors, thereby promoting MDV replication and viral infection (<xref ref-type="bibr" rid="ref13">13</xref>). <italic>ICP27</italic> is indispensable for viral replication, as it fosters early viral gene expression and DNA synthesis during productive infection (<xref ref-type="bibr" rid="ref14">14</xref>). Obviously, the latent infection and reactivation phases are crucial stages in preventing and controlling MDV infection during the early stages. These two key periods provide an opportunity to extensively investigate the molecular mechanism of MDV infection and find solutions for the current challenges associated with MD.</p>
<p>Sodium butyrate (NaB), a sodium salt derivative of butyric acid, has exhibited the ability to trigger programmed cell death, known as apoptosis, in various leukemia cell lines, including U937 (<xref ref-type="bibr" rid="ref15">15</xref>) and HL-60 cell lines (<xref ref-type="bibr" rid="ref16">16</xref>). Furthermore, recent investigations have unveiled the capacity of NaB to impede cell proliferation (<xref ref-type="bibr" rid="ref17">17</xref>), induce apoptosis (<xref ref-type="bibr" rid="ref18">18</xref>), and facilitate cell differentiation (<xref ref-type="bibr" rid="ref19">19</xref>) through the stimulation of histone hyperacetylation in cancer cells. Notably, both butyrate and propionate have demonstrated growth-inhibiting properties against colorectal adenocarcinoma cells (<xref ref-type="bibr" rid="ref20">20</xref>), along with a pronounced enhancement of apoptosis in cancer cells (<xref ref-type="bibr" rid="ref21">21</xref>). Similarly, in the context of breast cancer cells, NaB treatment has been observed to induce cell cycle arrest and foster apoptosis (<xref ref-type="bibr" rid="ref22 ref23 ref24">22&#x2013;24</xref>). In addition to the use of NaB in <italic>in vitro</italic> experiments, butyrate administration in mouse models has been found to diminish the occurrence of colon tumors induced by carcinogens, while also eliciting apoptosis in tumor cells (<xref ref-type="bibr" rid="ref25">25</xref>). Within the realm of poultry research, investigations primarily focus on exploring the effects of NaB on production performance, gut microbiology (<xref ref-type="bibr" rid="ref26">26</xref>), and its potential benefits in addressing gastrointestinal diseases in poultry (<xref ref-type="bibr" rid="ref27">27</xref>, <xref ref-type="bibr" rid="ref28">28</xref>). However, the impact of NaB on poultry viral diseases remains an area that warrants further exploration and understanding.</p>
<p>Given the importance of exploring the mechanism of lymphoma caused by MDV and the advantages of the role of NaB in promoting apoptosis of tumor cells, in this study, NaB was investigated <italic>in vivo</italic> and <italic>in vitro</italic> by using the MDV infected chicken model and MDV-transformed lymphoma cell, i.e., MSB-1, respectively.</p>
</sec>
<sec sec-type="materials|methods" id="sec2">
<label>2</label>
<title>Materials and methods</title>
<sec id="sec3">
<label>2.1</label>
<title>Ethics statement</title>
<p>All procedures involving animals in this research were conducted in accordance with the ethical standards of the institution or practice. The experiments were approved by the Ethics Committee for Animal Experiments of Foshan University (Ethical permit number: FOSU2008).</p>
</sec>
<sec id="sec4">
<label>2.2</label>
<title>Virus and cells</title>
<p>The highly pathogenic MDV Md5 strain and the MDV-transformed T-cell line MSB-1 (in suspension) were cultivated in our laboratory. The cells were nurtured in RPMI-1640 medium (Servicebio, China), supplemented with 10% FBS (Gibco, United States) and 1% antibiotic solution (penicillin 100&#x2009;U/mL, streptomycin 100&#x2009;g/mL; Beyotime, Jiangsu, China), and incubated at 37&#x00B0;C in a 5% CO<sub>2</sub> environment. Chicken embryonic fibroblasts (CEFs) were prepared from 9 to10-day-old specific pathogen-free (SPF) chicken embryos using conventional methods.</p>
</sec>
<sec id="sec5">
<label>2.3</label>
<title>CCK-8 assay</title>
<p>Cell Cytotoxicity/Viability Assay were performed using the CCK-8 Cell Counting Kit (Vazyme, Nanjing, China) in accordance with the manufacturer&#x2019;s instructions as described previously (<xref ref-type="bibr" rid="ref29">29</xref>). MSB-1 cells in the logarithmic growth phase were seeded in 96-well plates at a density of 5&#x2009;&#x00D7;&#x2009;10<sup>3</sup> cells per well. Subsequently, the cells were exposed to various concentrations of NaB (0, 2, 4, 6, 8, and10 mM) for a duration of 24&#x2009;h. The subsequent day, 10&#x2009;&#x03BC;L of CCK-8 solution were introduced, followed by an additional incubation period of 2&#x2009;h. Concurrently, the control cells were subjected to RPMI-1640 medium supplemented with 10% CCK-8.</p>
</sec>
<sec id="sec6">
<label>2.4</label>
<title>Plaque assay</title>
<p>Following the previously described method with some modifications (<xref ref-type="bibr" rid="ref29">29</xref>, <xref ref-type="bibr" rid="ref30">30</xref>), plaque assays were performed. Once the monolayer of CEF cells in a 96-well tissue culture plate reached confluency, the treatment group was infected with 20 PFU of the Md5 virus per well for 1&#x2009;h. After replacing the infection medium, NaB solution was added to a final concentration of 6&#x2009;mM, and the cells were incubated for 24&#x2009;h. Subsequently, the cells were covered with a 2% agarose gel containing an equal volume of 2&#x00D7; DMEM medium. For the prevention group, CEF cells were incubated with NaB solution (final concentration of 6&#x2009;mM) for 24&#x2009;h before viral infection, followed by the same infection protocol as the treatment group. The agarose gel was then applied. The number of cytopathic effect (CPE) lesions was observed daily and counted until no new CPEs were observed.</p>
</sec>
<sec id="sec7">
<label>2.5</label>
<title>Experimental design</title>
<p>Local chicken Nanhai Ephedra chickens, devoid of any prior immunization, were procured from Nanhai Breeder Co. The chickens did not receive any vaccination procedures throughout the experiment. The NaB reagent was obtained from Sigma-Aldrich Chemical Company (303,410, Sigma Aldrich, Germany). Based on the drug dosage mentioned in the referenced literature (<xref ref-type="bibr" rid="ref31">31</xref>) and subsequent conversions (<xref ref-type="bibr" rid="ref32">32</xref>) of drug dosages, the approximate administration doses of the drug in the experiment were calculated using conversion factors for dose equivalence between chickens and other experimental animals (<xref ref-type="bibr" rid="ref33">33</xref>). Building upon preliminary investigations, NaB was administered at a dose of 132&#x2009;mg/kg.</p>
<p>To ensure adequate and consistent absorption of NaB in the chickens, intraperitoneal injection was employed during the experiment. In the three groups of NaB, prevention, and treatment, chickens of each group were injected with 100&#x2009;&#x03BC;L of NaB solution. The groups of NaB and prevention were received the NaB injection 7&#x2009;day in advance (day &#x2212;7), the duration of NaB administration was 35&#x2009;days in total. The group of treatment was received the NaB injection at the same time as MD5 infection (day 0), the duration of NaB administration was 28&#x2009;days in total (<xref ref-type="fig" rid="fig1">Figure 1</xref>). While the two groups of Blank and Md5 were injected with an equal volume of PBS solution. The chickens in each group underwent bi-daily weighing, allowing for necessary adjustments in the injected amount of NaB based on their weights. A total of 120 1-day-old chickens were randomly allocated into five groups (<italic>n</italic>&#x2009;=&#x2009;24) and housed in separate enclosures. Animals infected with non-human infectious viruses are isolated from healthy animals throughout the experiment to prevent transmission. Intraperitoneal injection of Md5, 2,000 PFU/chicken, was administered to the chickens, as outlined in previous literature (<xref ref-type="bibr" rid="ref34">34</xref>). At each time point of dissection, five chickens were randomly selected from each group for sampling. Each spleen sample was tested with five replicates. Control groups included the Md5 group, NaB group, and blank group. Following Md5 infection, chickens were monitored daily for manifestations of MD, such as leg paralysis, head and neck rotation, blindness, tumor formation, and mortality. At the conclusion of the experimental period, surviving chickens were euthanized in a humane manner and subjected to dissection, focusing on organs like the liver, spleen, kidney, and heart, to assess the presence of internal tumors. The spleen index was calculated according to the formula, spleen index&#x2009;=&#x2009;weight of spleen (g) / body weight (g)&#x2009;&#x00D7;&#x2009;100 (<xref ref-type="bibr" rid="ref30">30</xref>). All chickens, whether deceased or alive, displaying MD symptoms or visibly detectable tumors were classified as MD cases. Cases that succumbed prematurely due to compromised autoimmunity or environmental factors within a week prior to the disease onset were excluded from analysis. Throughout the duration of animal experiments, restricted access, record keeping, animal isolation, sanitation and disinfection, sample collection, waste management, etc. have followed the relevant biosafety regulations, as detailed in <xref ref-type="supplementary-material" rid="SM1">Supplementary File 1</xref>.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Animal experimental design.</p>
</caption>
<graphic xlink:href="fvets-11-1360878-g001.tif"/>
</fig>
</sec>
<sec id="sec8">
<label>2.6</label>
<title>Sample collection and processing</title>
<p>On 7, 14, 28, and 50&#x2009;days post-infections (dpi), Chicks from the respective experimental cohorts were humanely terminated through exsanguination via the ruptured jugular vein and used diazepam as a sedative drug. For each time point, a minimum of three chicks from each group were euthanized, and spleen tissues were meticulously procured. The spleens were carefully weighed, and the spleen index was ascertained by computing the ratio of spleen weight to body weight. The procured tissues were subsequently delicately placed within 1.5&#x2009;mL sterile test tubes that were preloaded with 1&#x2009;mL of RNA Keeper Tissue Stabilizer (R501, Vazyme, Jiangsu, China). According to the reagent instructions, the samples were incubated overnight at 4&#x00B0;C and stored at &#x2212;80&#x00B0;C as previously described (<xref ref-type="bibr" rid="ref35">35</xref>).</p>
</sec>
<sec id="sec9">
<label>2.7</label>
<title>Histopathological observation</title>
<p>Spleen specimens were procured from chickens at various time intervals to facilitate the histopathological analysis. The specimens were meticulously preserved in a formaldehyde solution. Subsequently, the tissues underwent a process of alcohol dehydration, after which 5&#x2009;&#x03BC;m sections of paraffin-embedded spleen tissue were meticulously stained with the classic hematoxylin and eosin (H&#x0026;E) technique (<xref ref-type="bibr" rid="ref36">36</xref>). Following staining, the sections were subjected to dehydration using anhydrous ethanol, and subsequently rinsed in xylene to enhance transparency. Ultimately, the transparent sections were meticulously embedded in a neutral resin medium and examined under a light microscope.</p>
</sec>
<sec id="sec10">
<label>2.8</label>
<title>Fluorescence quantitative PCR</title>
<p>Total RNA was isolated from chicken spleen tissues utilizing TRIzol reagent (B511311, Sangon biotech, Shanghai, China). Subsequently, the RNA samples were subjected to reverse transcription using Hiscript&#x00AE; III All-in-One RT SuperMix Perfect for qPCR reverse transcriptase (Vazyme, Nanjing, China). Each sample was employed to evaluate the expression of MDV genes and host mitochondrial apoptosis pathway genes. The quantitative fluorescence detection instrument employed was the Thermo QuantStudio 5, and the qPCR reaction system consisted of a 20&#x2009;&#x03BC;L volume. This system encompassed 10&#x2009;&#x03BC;L of Hieff UNICON&#x00AE; Universal Blue qPCR SYBR Green Master Mix, 0.5&#x2009;&#x03BC;L each of upstream and downstream primers (10&#x2009;&#x03BC;mol/L), 1&#x2009;&#x03BC;L of cDNA, and the remaining volume was adjusted to 20&#x2009;&#x03BC;L using ddH<sub>2</sub>O. Following pre-denaturation at 95&#x00B0;C for 2&#x2009;min, amplification was conducted for 40&#x2009;cycles (95&#x00B0;C for 10&#x2009;s, 60&#x00B0;C for 30&#x2009;s). Each sample was tested in triplicate, and the data are presented as mean&#x2009;&#x00B1;&#x2009;SD. Relative quantification of the genes was determined using the 2<sup>&#x2212;&#x2206;&#x2206;CT</sup> method. The primer sequences used are depicted in <xref ref-type="table" rid="tab1">Table 1</xref> (<xref ref-type="bibr" rid="ref37">37</xref>, <xref ref-type="bibr" rid="ref38">38</xref>, <xref ref-type="bibr" rid="ref40">40</xref>).</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Sequences of qPCR primers.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Primers</th>
<th align="left" valign="top">Reverse (5&#x2032;-3&#x2032;)</th>
<th align="left" valign="top">Forward (5&#x2032;-3&#x2032;)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">TNF-&#x03B1; (<xref ref-type="bibr" rid="ref37">37</xref>)</td>
<td align="left" valign="middle">ACTATCCTCACCCCTACCCTGTC</td>
<td align="left" valign="middle">GGTCATAGAACAGCACTACGGG</td>
</tr>
<tr>
<td align="left" valign="middle">FADD (<xref ref-type="bibr" rid="ref38">38</xref>)</td>
<td align="left" valign="middle">ACTGGAAAATGCTGATGCGA</td>
<td align="left" valign="middle">CCACTCTCGAAGCGACTGAAA</td>
</tr>
<tr>
<td align="left" valign="middle">TRADD (<xref ref-type="bibr" rid="ref38">38</xref>)</td>
<td align="left" valign="middle">ACAACAGAACGCTCACACCA</td>
<td align="left" valign="middle">TCCCTCTCGGTCGTATTCGT</td>
</tr>
<tr>
<td align="left" valign="middle">PARP</td>
<td align="left" valign="middle">AAAACGTGCTGCTGAAGTGT</td>
<td align="left" valign="middle">GCTCCAGGGATTCATTGGCT</td>
</tr>
<tr>
<td align="left" valign="middle">MCL-1 (<xref ref-type="bibr" rid="ref39">39</xref>)</td>
<td align="left" valign="middle">GTGCCTTTGTGGCTAAACACT</td>
<td align="left" valign="middle">AGTCCCGTTTTGTCCTTACGA</td>
</tr>
<tr>
<td align="left" valign="middle">Bak</td>
<td align="left" valign="middle">CGTCTACCAGCAAGGCATCA</td>
<td align="left" valign="middle">ATTGTCCAGATCGAGTGCAGC</td>
</tr>
<tr>
<td align="left" valign="middle">Caspase-8</td>
<td align="left" valign="middle">TGGCATGGCTACTGTGGAAG</td>
<td align="left" valign="middle">TGAGATCCTTGCGAAGTGGG</td>
</tr>
<tr>
<td align="left" valign="middle">BCL2</td>
<td align="left" valign="middle">AGAGCGTCAACCGGGAGAT</td>
<td align="left" valign="middle">CCACAAAGGCATCCCATCCT</td>
</tr>
<tr>
<td align="left" valign="middle">Caspase-3</td>
<td align="left" valign="middle">ACTGTCATCTCGTTCAGGCA</td>
<td align="left" valign="middle">TGCTTCGCTTGCTGTGATCT</td>
</tr>
<tr>
<td align="left" valign="middle">Caspase-9</td>
<td align="left" valign="middle">GCCTGTGGAGGAGAACAAAAG</td>
<td align="left" valign="middle">GTCTGGCTCGTCCTCATTCC</td>
</tr>
<tr>
<td align="left" valign="middle">ARRDC3</td>
<td align="left" valign="middle">CGGCCACGAGAGAGATGATG</td>
<td align="left" valign="middle">TTCACCCAATAGCGCACACT</td>
</tr>
<tr>
<td align="left" valign="middle">BAX</td>
<td align="left" valign="middle">GCACAGCTTTATCCGCAAGG</td>
<td align="left" valign="middle">CGCACAGGTGAGACAAAGGT</td>
</tr>
<tr>
<td align="left" valign="middle">CytC</td>
<td align="left" valign="middle">AAATGTTCCCAGTGCCATACG</td>
<td align="left" valign="middle">TTGTCCTGTTTTGCGTCCAA</td>
</tr>
<tr>
<td align="left" valign="middle">Apaf-1</td>
<td align="left" valign="middle">AAGGGCATAAGGAAGCAATC</td>
<td align="left" valign="middle">CAGTTTTGTCAGCAGAAGTAG</td>
</tr>
<tr>
<td align="left" valign="middle">Meq</td>
<td align="left" valign="middle">CGTCTTACCGAGGATCCCGAA</td>
<td align="left" valign="middle">TCCCGTCACCTGGAAACCAC</td>
</tr>
<tr>
<td align="left" valign="middle">ICP27</td>
<td align="left" valign="middle">TCCGATGAAAATGCCGAAGTGA</td>
<td align="left" valign="middle">GGAATCAGGAGATGGTCGTTCGGTCAA</td>
</tr>
<tr>
<td align="left" valign="middle">ICP4</td>
<td align="left" valign="middle">CTATGGCAGACATCGCTCGT</td>
<td align="left" valign="middle">GTATCGCATCCAAGCAGTCC</td>
</tr>
<tr>
<td align="left" valign="middle">PTEN</td>
<td align="left" valign="middle">GGAAAGGGACGAACTGGTGT</td>
<td align="left" valign="middle">CCGCCACTGAACATGGGAAT</td>
</tr>
<tr>
<td align="left" valign="middle">TGF-&#x03B2;</td>
<td align="left" valign="middle">GGAGCTGTACCAGGGTTACG</td>
<td align="left" valign="middle">AAGGAGAGCCACTCATCGTC</td>
</tr>
<tr>
<td align="left" valign="middle">&#x03B2;-actin</td>
<td align="left" valign="middle">GATATTGCTGCGCTCGTTGTT</td>
<td align="left" valign="middle">ACCAACCATCACACCCTGA</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec11">
<label>2.9</label>
<title>TUNEL assay</title>
<p>Apoptosis was detected in the spleens of each group at 7 dpi using the TUNEL apoptosis detection kit (40306ES20, Yeasen, Shanghai, China) (<xref ref-type="bibr" rid="ref39">39</xref>). Tissue sections were deparaffinized in xylene, followed by immersion in anhydrous ethanol for 5&#x2009;min and sequential washes in gradient ethanol (90, 80, 70%) for 1 time each, with a duration of 3&#x2009;min per wash. After rinsing the sections with PBS, proteinase K solution was added and incubated at room temperature for 20&#x2009;min. Subsequently, the sections were washed with PBS and incubated with TDT enzyme, dUTP, and buffer solution. The sections were then incubated at 37&#x00B0;C without light for 60&#x2009;min. After washing the samples three times with PBS, DAPI solution was applied to stain the cell nuclei for 10&#x2009;min at room temperature. Following sample washing, fluorescence microscopy was used for examination and image acquisition. DAPI emits blue light with an excitation wavelength of 330&#x2013;380&#x2009;nm and an emission wavelength of 420&#x2009;nm, while FITC emits green fluorescence with an excitation wavelength of 465&#x2013;495&#x2009;nm and an emission wavelength of 515&#x2013;555&#x2009;nm.</p>
</sec>
<sec id="sec12">
<label>2.10</label>
<title>Transwell assay</title>
<p>To assess the impact of NaB on cellular migration, the MSB-1 cells were cultivated in the upper compartment of 8&#x2009;&#x03BC;m Transwell plates, with a density of 10<sup>5</sup> cells per well, and immersed in 200&#x2009;&#x03BC;L of serum-free medium. In the lower compartment, a 10% FBS solution was carefully introduced. NaB was then introduced into the medium to reach a final concentration of 6&#x2009;mM. The wells were subsequently incubated under optimal conditions of 37&#x00B0;C and 5% CO<sub>2</sub> for a duration of 24&#x2009;h. Following the incubation period, the cells were meticulously fixed with a formaldehyde solution for a period of 30&#x2009;min. Subsequently, a 0.4% crystal violet solution was employed to stain the cells for a duration of 10&#x2009;min at ambient temperature. To evaluate the efficacy of the treatment, five microscopic fields were randomly selected, and images were acquired utilizing a fluorescence microscope (Revolve FL, Echo Laboratories, United States) with a magnification of 100&#x2009;&#x00D7;&#x2009;.</p>
</sec>
<sec id="sec13">
<label>2.11</label>
<title>Soft agar colony formation</title>
<p>To assess the impact of NaB on MSB-1 clone formation, a colony formation assay in soft agar was conducted. The experiment was conducted according to the method described by Stanley Borowicz et al. (<xref ref-type="bibr" rid="ref41">41</xref>). The procedure involved preparing the bottom gel layer by mixing 1.2% agar with 2&#x00D7; medium in equal volumes, which was then spread as the bottom layer in 6-well plates. The plates were incubated at 37&#x00B0;C for 30&#x2009;min to allow the gel to solidify. Subsequently, 6&#x2009;&#x00D7;&#x2009;10<sup>3</sup> MSB-1 cells were mixed with 0.7% agar and added to the plates as the upper gel layer. In the NaB group, a NaB solution was added to the upper gel layer to achieve a concentration of 6&#x2009;mM. To prevent excessive drying, 100&#x2009;&#x03BC;L of complete medium was added after solidification. After a two-week incubation period, the colonies were observed under a microscope, manually counted, and photographed for analysis.</p>
</sec>
<sec id="sec14">
<label>2.12</label>
<title>Flow cytometry</title>
<p>To assess the impact of NaB on MSB-1 apoptosis, a flow cytometry assay was conducted. Cells were treated with or without NaB at a final concentration of 6&#x2009;mM for 24&#x2009;h. Subsequently, the cells were suspended and stained with Annexin V-FITC and propidium iodide (PI) according to the instructions provided with the Annexin V-FITC/PI Apoptosis Kit (Elabscience, China), as described by Han et al. (<xref ref-type="bibr" rid="ref42">42</xref>). The resulting data were analyzed using Flow Jo V10 software for further interpretation.</p>
</sec>
<sec id="sec15">
<label>2.13</label>
<title>Statistical analysis</title>
<p>The data from this experiment were presented as mean&#x2009;&#x00B1;&#x2009;S.D. Statistical analysis was performed using SPSS 26.0 (SPSS Inc., Chicago, United States). The Morbidity and mortality were analyzed by SPSS Chi-Square comparing between each group and results are presented in <xref ref-type="table" rid="tab2">Table 2</xref>. For normally distributed data, the experimental groups were compared using one-way ANOVA followed by the Tukey test. In the case of non-normally distributed data, the Dunnett&#x2019;s T3 test was applied. The Dunnett&#x2019;s T3 test was chosen because it is robust to the analysis of unequal variances (<xref ref-type="bibr" rid="ref43">43</xref>). For the comparison of two treatments, the Student&#x2019;s two-tailed t-test was employed. A significance level of <italic>p&#x2009;&#x003C;</italic> 0.05 was considered statistically significant. Data visualization was accomplished by GraphPad software (CA, United States).</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>Morbidity after attack by Md5 strain.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Groups</th>
<th align="center" valign="top">Total numbers</th>
<th align="center" valign="top">Diseased birds</th>
<th align="center" valign="top">Morbidity (%)</th>
<th align="center" valign="top">Deaths</th>
<th align="center" valign="top">Mortality (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">NaB+Md5 (prevention group)</td>
<td align="center" valign="middle">23</td>
<td align="center" valign="middle">2</td>
<td align="center" valign="middle">8.7%<sup>a,b</sup></td>
<td align="center" valign="middle">1</td>
<td align="center" valign="middle">4.30%</td>
</tr>
<tr>
<td align="left" valign="middle">Md5&#x2009;+&#x2009;NaB (treatment group)</td>
<td align="center" valign="middle">22</td>
<td align="center" valign="middle">2</td>
<td align="center" valign="middle">9.1%<sup>a,b</sup></td>
<td align="center" valign="middle">1</td>
<td align="center" valign="middle">4.50%</td>
</tr>
<tr>
<td align="left" valign="middle">Md5</td>
<td align="center" valign="middle">24</td>
<td align="center" valign="middle">7</td>
<td align="center" valign="middle">29.2%<sup>b</sup></td>
<td align="center" valign="middle">2</td>
<td align="center" valign="middle">8.30%</td>
</tr>
<tr>
<td align="left" valign="middle">NaB</td>
<td align="center" valign="middle">24</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0%<sup>a</sup></td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0%</td>
</tr>
<tr>
<td align="left" valign="middle">Blank</td>
<td align="center" valign="middle">24</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0%<sup>a</sup></td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0%</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>Total number&#x2009;=&#x2009;number of non-pathologically death. All the birds showing clinical MD symptoms, death and survivals with gross tumors were classified as MD cases. Morbidity (%)&#x2009;=&#x2009;number of MD cases / total number &#x00D7; 100. Mortality (%)&#x2009;=&#x2009;number of death / total number &#x00D7; 100. Different letter means significant difference (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05).</p>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec sec-type="results" id="sec16">
<label>3</label>
<title>Results</title>
<sec id="sec17">
<label>3.1</label>
<title>Effect of NaB on cytotoxicity in CEF cells</title>
<p>The safety concentration of NaB on CEF cells was evaluated using the CCK-8 assay as a preliminary step. As shown in <xref ref-type="fig" rid="fig2">Figure 2A</xref>, the cell viability was not affected in the experimental groups compared to the control group across different concentrations of NaB.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Cytotoxicity assay of CEF cells and statistics of CPE quantity. <bold>(A)</bold> The results of the cytotoxicity assay of CEF cells. <bold>(B)</bold> Statistical analysis of CPEs in plaque assay. &#x002A;, &#x002A; &#x002A;, &#x002A;&#x002A;&#x002A;: statistically significant at <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001 compared with mock group.</p>
</caption>
<graphic xlink:href="fvets-11-1360878-g002.tif"/>
</fig>
</sec>
<sec id="sec18">
<label>3.2</label>
<title>Effect of NaB on MDV replication in CEF cells</title>
<p>The impact of NaB on MDV replication was assessed using a plaque assay. As shown in <xref ref-type="fig" rid="fig2">Figure 2B</xref>, both the prevention and treatment groups exhibited a general trend where a higher concentration of NaB resulted in a lower number of CPE. In the prevention group, the lowest number of CPE was observed at the concentration of 8&#x2009;mM, while in the treatment group, the lowest number of affected cells was observed at 6&#x2009;mM.</p>
</sec>
<sec id="sec19">
<label>3.3</label>
<title>Effect of NaB on mortality and morbidity in different groups</title>
<p>The tumor tissues were collected from each group and subjected to histological examination. Cumulative morbidity, mortality, and tumor incidence were evaluated for all groups of birds, except for those that died prematurely due to non-specific causes prior to the Md5 challenge. Compared to the Md5 group, both the prevention group and the treatment group that received intraperitoneal injection of sodium butyrate had lower tumor incidence and mortality rates (<xref ref-type="table" rid="tab2">Table 2</xref>).</p>
</sec>
<sec id="sec20">
<label>3.4</label>
<title>Effect of NaB on spleen lesions</title>
<p>Necropsy was performed on all chickens to assess the presence of tumors in internal organs, with the findings depicted in <xref ref-type="fig" rid="fig3">Figure 3</xref>. At 50 dpi, the Md5 group exhibited visually detectable tumor lesions in the spleen, which displayed significant enlargement compared to the other groups (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). The presence of tumorous lesions in the spleen of the Md5 group results in an increase in both the weight and volume of the spleen. <xref ref-type="fig" rid="fig3">Figure 3K</xref> demonstrates a difference in splenic index in each group. No significant difference in spleen index was observed among the prevention group, treatment group, and blank group, which indicates the NaB in prevention and treatment groups did not cause splenomegaly.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Histological lesions of spleen and index of spleen. Panels <bold>(A,C,E,G,I)</bold> show the spleens of the Md5 group, prevention group, treatment group, blank group and NaB group, respectively. Panels <bold>(B,D,F,H,J)</bold> show the sectioned images (40&#x00D7;) of each group. Black arrowheads indicate necrotic foci; Yellow arrowheads indicate inflammatory cell infiltration; Red arrowheads indicate reticular cell hyperplasia. Panel <bold>(K)</bold> shows the spleen index of each group at 50 dpi.</p>
</caption>
<graphic xlink:href="fvets-11-1360878-g003.tif"/>
</fig>
</sec>
<sec id="sec21">
<label>3.5</label>
<title>Effect of NaB on viral genes of MDV in spleen</title>
<p>The MDV immediate-early gene <italic>ICP4</italic> is a transcription activator that is an essential factor for early and late promoter for viral gene expression (<xref ref-type="bibr" rid="ref44">44</xref>), while another immediate-early gene <italic>ICP27</italic> is known to be required for efficient expression of some viral DNA replication-related early genes and late viral genes as well as for virus growth (<xref ref-type="bibr" rid="ref14">14</xref>). The quantification of <italic>ICP4</italic> and <italic>ICP27</italic>, along with MDV oncogene <italic>Meq</italic>, was assessed in the spleen using qPCR. Regarding the <italic>ICP4</italic> gene, treatment with NaB led to a substantial downregulation at all four time points in both the prevention and treatment groups, relative to the Md5 control group. Interestingly, at 28 dpi and 50 dpi, the prevention group displayed a significantly greater inhibition of <italic>ICP4</italic> expression compared to the treatment group, as illustrated in <xref ref-type="fig" rid="fig4">Figure 4A</xref>. Regarding the <italic>ICP27</italic> gene, no significant changes in expression were observed at 7 dpi among the three groups. However, a significant suppression was detected in both the prevention and treatment groups at 14 dpi, when compared to the Md5 control group. It is noteworthy that this suppression effect was reversed at 28 dpi and 50 dpi, as depicted in <xref ref-type="fig" rid="fig4">Figure 4B</xref>. In relation to the oncogene <italic>Meq</italic>, a notable reduction in relative expression was observed in both the prevention and treatment groups at 7, 14, 28, and 50 dpi, when compared to the Md5 control group. Furthermore, at 28 dpi, the treatment group exhibited a significantly more pronounced inhibition of <italic>Meq</italic> expression compared to the prevention group, as depicted in <xref ref-type="fig" rid="fig4">Figure 4C</xref>.</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>Expression of viral genes of MDV in the spleen. &#x002A;, &#x002A; &#x002A;, &#x002A;&#x002A;&#x002A;: statistically significant at <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001 between groups. <bold>(A)</bold> Relative expression of <italic>ICP4</italic>. <bold>(B)</bold> Relative expression of <italic>ICP27</italic>. <bold>(C)</bold> Relative expression of <italic>Meq</italic>.</p>
</caption>
<graphic xlink:href="fvets-11-1360878-g004.tif"/>
</fig>
</sec>
<sec id="sec22">
<label>3.6</label>
<title>Effect of NaB on tumor-suppressive genes of spleen</title>
<p>Effect of NaB on tumor-suppressor genes in MD5 infected chicken spleen, such as <italic>PTEN</italic>, <italic>TGF-&#x03B2;</italic>, and <italic>ARRDC3</italic>, within each experimental group are depicted in <xref ref-type="fig" rid="fig5">Figure 5</xref>. Notably, a profound upregulation of <italic>PTEN</italic> was observed in the prevention group at 14, 28, and 50 dpi, as compared to the Md5 control group (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Furthermore, at 50 dpi, the expression of <italic>TGF-&#x03B2;</italic> surpassed that of the other three groups within the prevention group, indicating a potential role in tumor suppression (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Interestingly, the expression of <italic>ARRDC3</italic> exhibited a significant upregulation at both 7 and 50 dpi, highlighting its involvement in the prevention group when compared to the Md5 control group.</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>Expression of tumor suppressive genes in spleen. Different letter means significant difference (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05). <bold>(A)</bold> Relative expression of PTEN. <bold>(B)</bold> Relative expression of TGF-<italic>&#x03B2;</italic>. <bold>(C)</bold> Relative expression of <italic>ARRDC3</italic>.</p>
</caption>
<graphic xlink:href="fvets-11-1360878-g005.tif"/>
</fig>
</sec>
<sec id="sec23">
<label>3.7</label>
<title>Effect of NaB on splenic apoptosis</title>
<p>To explore the apoptosis in the spleen at 7 dpi after MDV infection, we conducted a TUNEL assay on spleen tissues. The results, as depicted in <xref ref-type="fig" rid="fig6">Figure 6</xref>, reveal a significant increase in green fluorescence signals within both the prevention and treatment groups, as compared to the Md5 group. <xref ref-type="fig" rid="fig6">Figure 6B</xref> further presents a quantitative representation of the extent of apoptosis in splenocytes. Remarkably, the treatment and prevention groups exhibited higher levels of apoptosis, followed by the Md5 group.</p>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption>
<p>The TUNEL assay of spleen. <bold>(A)</bold> The DAPI (blue) and TUNEL (green) staining of each group. <bold>(B)</bold> The quantify of TUNEL assay of each group.</p>
</caption>
<graphic xlink:href="fvets-11-1360878-g006.tif"/>
</fig>
</sec>
<sec id="sec24">
<label>3.8</label>
<title>Effect of NaB on MSB-1 proliferation</title>
<p>In order to ascertain the suppressive impact of NaB on cellular proliferation, a cohort of MSB-1 cells were subjected to incubation with varying concentrations of NaB for a duration of 24&#x2009;h. The outcomes of this experimental endeavor are depicted in <xref ref-type="fig" rid="fig7">Figure 7</xref>. Upon administration of a 2&#x2009;mM concentration of NaB, no substantial alteration in the vitality of MSB-1 cells was observed. However, once the concentration of NaB reached or surpassed 4&#x2009;mM, a propensity to impede the proliferation of MSB-1 cells became readily apparent.</p>
<fig position="float" id="fig7">
<label>Figure 7</label>
<caption>
<p>The CCK-8 assay on MSB-1 treated with NaB. Different letter means significant difference (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05).</p>
</caption>
<graphic xlink:href="fvets-11-1360878-g007.tif"/>
</fig>
</sec>
<sec id="sec25">
<label>3.9</label>
<title>Effect of NaB on MSB-1 migration and clone formation</title>
<p>In order to assess the impact of NaB on cellular migration, we conducted a Transwell assay on MSB-1 cells. Following a 24-h migration period, cells were stained and subsequently examined under a fluorescence microscope. Our observations revealed a noteworthy suppression of cell migration in the experimental group, wherein an additional 6&#x2009;mM NaB was administered (<xref ref-type="fig" rid="fig8">Figures 8A</xref>&#x2013;<xref ref-type="fig" rid="fig8">C</xref>). To further explore the influence of NaB on cellular migration, a soft agar colony assay was performed. Remarkably, the treatment of MSB-1 cells with NaB resulted in a considerable reduction in both clone size and cell count when compared to the control group (<xref ref-type="fig" rid="fig8">Figures 8D</xref>&#x2013;<xref ref-type="fig" rid="fig8">F</xref>).</p>
<fig position="float" id="fig8">
<label>Figure 8</label>
<caption>
<p>Transwell and soft agar cloning assays on MSB-1 cells. The migration of cells under a fluorescence microscope in the mock <bold>(A)</bold> and NaB group <bold>(B)</bold> and the cell clone formation in Mock group <bold>(D)</bold> and NaB group <bold>(E)</bold> were captured under a magnification of 200&#x00D7;. The number of migrated cells and clones were quantified respectively, statistical analyses were presented in <bold>(C)</bold> and <bold>(F)</bold>. &#x002A;, &#x002A; &#x002A;, &#x002A;&#x002A;&#x002A; indicates the <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.01 and <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001, respectively.</p>
</caption>
<graphic xlink:href="fvets-11-1360878-g008.tif"/>
</fig>
</sec>
<sec id="sec26">
<label>3.10</label>
<title>Effect of NaB on MSB-1 apoptosis</title>
<p>In order to assess the occurrence of programmed cell death in MSB-1 cells, a flow cytometry assay was conducted subsequent to the administration of various concentrations of NaB for a duration of 24&#x2009;h. The concentrations tested ranged from 0 to 10&#x2009;mM (<xref ref-type="fig" rid="fig9">Figure 9A</xref>). The resulting data was analyzed and represented graphically in <xref ref-type="fig" rid="fig9">Figure 9B</xref>, highlighting the distribution of cells within the quadrants Q1, Q2, Q3, and Q4. These quadrants are indicative of the quantities of dead cells, late apoptotic cells, early apoptotic cells and lived cells, respectively.</p>
<fig position="float" id="fig9">
<label>Figure 9</label>
<caption>
<p>Flow cytometry of apoptosis in MSB-1 cell treated with different concentration of NaB. <bold>(A)</bold> Plots of apoptosis in MSB-1 cell via flow cytometry. <bold>(B)</bold> Quantitative analysis. Different letters above the columns mean there is significant difference (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05).</p>
</caption>
<graphic xlink:href="fvets-11-1360878-g009.tif"/>
</fig>
</sec>
<sec id="sec27">
<label>3.11</label>
<title>Effect of NaB on the mitochondrial apoptosis pathway</title>
<p>To elucidate the molecular mechanism underlying the induction of apoptosis in MSB-1 cells by NaB, we assessed alterations in the transcriptional levels of cytokines associated with the mitochondrial apoptotic pathway. As a control, we incorporated Mdivi-1, a known inhibitor of mitochondrial outer membrane permeabilization that consequently retards apoptosis (<xref ref-type="bibr" rid="ref45">45</xref>). The experimental framework comprised three distinct groups: NaB, mock, and Mdivi-1. The qPCR analysis revealed that NaB significantly enhanced the expression of <italic>TNF-&#x03B1;</italic>, <italic>FADD</italic>, and <italic>TRADD</italic> (<xref ref-type="fig" rid="fig10">Figures 10A</xref>&#x2013;<xref ref-type="fig" rid="fig10">C</xref>). Additionally, we observed a decrease in the <italic>BCL2</italic>/<italic>Bax</italic> ratio in the NaB group, with the former being an anti-apoptotic protein and the latter a pro-apoptotic protein (<xref ref-type="fig" rid="fig10">Figure 10D</xref>). Furthermore, compared to the control group and Mdivi-1 group, the NaB group exhibited a significant increase in the activity of <italic>Bak</italic>, <italic>CytC</italic>, <italic>Apaf-1</italic>, <italic>Caspase-9</italic>, <italic>Caspase-8</italic>, Caspase<italic>-3</italic>, and decreased expression of <italic>PARP</italic> in MSB-1 cells (<xref ref-type="fig" rid="fig10">Figures 10E</xref>&#x2013;<xref ref-type="fig" rid="fig10">K</xref>).</p>
<fig position="float" id="fig10">
<label>Figure 10</label>
<caption>
<p>Expression of molecules in mitochondrial apoptosis signaling pathway and tumor related genes. <bold>(A&#x2013;K)</bold> Relative expression of mitochondrial apoptosis signaling pathway related genes. <bold>(L&#x2013;N)</bold> Relative expression of tumor suppressive genes. <bold>(O)</bold> Relative expression of oncogene <italic>Meq</italic>. &#x002A;, &#x002A; &#x002A;, &#x002A;&#x002A;&#x002A;: statistically significant at <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001 between groups, respectively.</p>
</caption>
<graphic xlink:href="fvets-11-1360878-g010.tif"/>
</fig>
</sec>
<sec id="sec28">
<label>3.12</label>
<title>Effect of NaB on tumor suppressive genes in MSB-1</title>
<p>The expression of several tumor suppressive genes, such as <italic>PTEN</italic>, <italic>ARRDC3</italic>, and <italic>TGF-&#x03B2;</italic>, was investigated in MSB-1 cells after 24&#x2009;h of NaB treatment. <italic>PTEN</italic>, an extensively studied tumor suppressor (<xref ref-type="bibr" rid="ref46">46</xref>), plays a crucial role in tumor suppression. Down-regulation of <italic>ARRDC3</italic> promotes tumor cell proliferation and inhibits apoptosis (<xref ref-type="bibr" rid="ref47">47</xref>). In the early stages of tumor progression, <italic>TGF-&#x03B2;</italic> acts as a tumor suppressor (<xref ref-type="bibr" rid="ref48">48</xref>). Our experimental results demonstrated that NaB enhances the expression of these three tumor suppressive genes mentioned above. Therefore, it was postulated that NaB may hinder tumor progression by stimulating the expression of anti-tumor genes (<xref ref-type="fig" rid="fig10">Figures 10L</xref>,<xref ref-type="fig" rid="fig10">N</xref>). The oncogene <italic>Meq</italic>, encoded by MDV, plays a critical role in lymphocyte transformation (<xref ref-type="bibr" rid="ref49">49</xref>). Notably, our experimental findings indicate that NaB substantially inhibits <italic>Meq</italic> expression (<xref ref-type="fig" rid="fig10">Figure 10O</xref>).</p>
</sec>
</sec>
<sec sec-type="discussion" id="sec29">
<label>4</label>
<title>Discussion</title>
<p>In this study, utilizing MD5-infected chickens as our experimental model, we have shown that NaB possesses the ability to impede the replication of MDV via inhibiting the expression of immediate early (IE) genes <italic>ICP4</italic> and <italic>ICP27</italic>, which are crucial for lytic infection of MDV (<xref ref-type="bibr" rid="ref50">50</xref>). Following an initial burst of lytic infection, T-lymphocytes become latently infected with MDV (<xref ref-type="bibr" rid="ref51">51</xref>). Subsequently, chickens infected with virulent strain of MDV develop aggressive T-cell lymphomas (<xref ref-type="bibr" rid="ref52">52</xref>). Notably, the majority of transcripts found in MDV lymphoblastoid cells are derived from IE genes (<xref ref-type="bibr" rid="ref53">53</xref>), suggesting that these genes may play a significant role in the maintenance of latency (<xref ref-type="bibr" rid="ref51">51</xref>). Our experimental findings provide compelling evidence that NaB shows a remarkable ability to reduce the morbidity of lymphomas in chickens following Md5 infection. Furthermore, NaB exhibits a significant capacity to suppress the oncogene <italic>Meq</italic> and upregulates the tumor suppressive genes such as <italic>Meq</italic> and <italic>ARRDC3</italic> in spleen, thereby positively influencing anti-tumor performance. The inhibitory effect of NaB on lymphomas may be attributed to its inhibition of IE genes, including <italic>ICP4</italic> and <italic>ICP27</italic>. Accumulated evidence to date suggests that <italic>ICP4</italic> may be associated with lytic infection and latency, with latently infected lymphocytes contributing to 75% of lymphoma (<xref ref-type="bibr" rid="ref54">54</xref>). Latent infection of T-lymphocytes is a prerequisite to malignant transformation and neoplastic disease (<xref ref-type="bibr" rid="ref55">55</xref>). However, the mechanism underlying MDV-induced latency and oncogenesis remains poorly understood.</p>
<p>Apoptosis plays a pivotal role in the regulation of physiological growth and maintenance of tissue homeostasis. Our <italic>in vivo</italic> and <italic>in vitro</italic> experiments have shown that NaB can lead to apoptosis in MDV induced lymphomas cells. The apoptotic pathways encompass two major categories: endogenous and exogenous pathways (<xref ref-type="bibr" rid="ref56">56</xref>). The endogenous pathway, known as the mitochondrial pathway, is a highly conserved mechanism of cell death that is indispensable for the development and sustenance of multicellular organisms (<xref ref-type="bibr" rid="ref57">57</xref>). Our research further found that, in contrast to the mitochondrial apoptosis signaling pathway inhibitor Mdivi-1, NaB exhibits the ability to enhance the expression of the pivotal molecules in the mitochondrial signaling pathway, such as TNF<italic>-&#x03B1;</italic>, <italic>FADD</italic>, <italic>TRADD</italic>, <italic>BCL2</italic>, <italic>Bax</italic>, <italic>CytC</italic>, <italic>Apaf-1</italic>, <italic>Caspase-8/9/3</italic> etc. Intriguingly, our experimental findings are consistent with previous reports. Numerous investigations have unveiled the inhibitory effects of NaB on tumor cell proliferation and its ability to promote apoptosis both <italic>in vitro</italic> and <italic>in vivo</italic>. For instance, effectiveness has been demonstrated against prostate cancer cells DU145 and PC3 (<xref ref-type="bibr" rid="ref58">58</xref>), lung cancer cells A549 (<xref ref-type="bibr" rid="ref59">59</xref>), and gastric cancer cells GC (<xref ref-type="bibr" rid="ref60">60</xref>). Alterations in mitochondrial permeability are central to the initiation of the mitochondrial apoptotic pathway, which involves the interconnected activation of Caspase molecules and pro-apoptotic members of the BCL family (<xref ref-type="bibr" rid="ref61">61</xref>). Furthermore, the delicate equilibrium between pro- and anti-apoptotic BCL2 proteins determines the propensity of tumor cells to undergo apoptosis (<xref ref-type="bibr" rid="ref62">62</xref>). Additionally, our experiments have elucidated that stimulation of NaB in MSB-1 cells can attenuate the <italic>BCL2</italic> to <italic>BAX</italic> ratio, consequently inducing apoptosis. These results suggest that NaB can achieve tumor cell apoptosis by regulating the mitochondrial apoptosis signaling pathway. The model of molecular mechanism is depicted in <xref ref-type="fig" rid="fig11">Figure 11</xref>, which expands the role of NaB in avian tumor.</p>
<fig position="float" id="fig11">
<label>Figure 11</label>
<caption>
<p>Molecular mechanisms of apoptosis mediated by Sodium Butyrate.</p>
</caption>
<graphic xlink:href="fvets-11-1360878-g011.tif"/>
</fig>
<p>Presently, vaccination serves as the primary approach for managing MD in chickens. However, despite the widespread utilization of the CVI988 vaccine in poultry flocks, MD cases continue to be reported in various regions in recent years (<xref ref-type="bibr" rid="ref63">63</xref>, <xref ref-type="bibr" rid="ref64">64</xref>). Some investigations have raised concerns regarding the potential of the CVI988 vaccine to promote viral virulence (<xref ref-type="bibr" rid="ref27">27</xref>) and recombination between vaccine strains and field strains (<xref ref-type="bibr" rid="ref65">65</xref>). Given the absence of pharmacological treatments for avian MD tumors, exploring the potential of combining pharmacological interventions with vaccination could prove beneficial. Our data suggested the NaB is a potential prophylactic candidate which could be further investigated in the field of immunosuppressive neoplasia in chickens. Further investigation is warranted to delve into the implementation of NaB in the realm of practical production, with a specific emphasis on its convenience, cost-effectiveness, and efficacy in impeding the progression of MDV.</p>
<p>Consequently, our data showed that NaB has the potential to be incorporated into chicken lymphoma prevention and treatment regimens and contribute to the study of viral diseases in animals. We propose the consideration of incorporating an appropriate dosage of sodium butyrate into standard chicken diets as a potential approach to alleviate the clinical challenges attributed to MD.</p>
</sec>
<sec sec-type="conclusions" id="sec30">
<label>5</label>
<title>Conclusion</title>
<p>In conclusion, our experiments establish that NaB exerts a potent inhibitory effect on lymphoma caused by MDV engaging the mitochondrial apoptotic pathway. Consequently, the utilization of NaB, a histone deacetylase inhibitor, warrants serious contemplation as a promising avenue for MDV prevention.</p>
</sec>
<sec sec-type="data-availability" id="sec31">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="ethics-statement" id="sec32">
<title>Ethics statement</title>
<p>The animal study was approved by Ethics Committee for Animal Experiments of Foshan University. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="sec33">
<title>Author contributions</title>
<p>QL: Data curation, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing, Formal Analysis, Software. JZ: Data curation, Methodology, Writing &#x2013; review &#x0026; editing, Validation. FY: Data curation, Methodology, Validation, Writing &#x2013; review &#x0026; editing, Investigation. CZ: Investigation, Writing &#x2013; review &#x0026; editing, Formal Analysis, Software. MC: Writing &#x2013; review &#x0026; editing, Methodology, Validation. CC: Validation, Writing &#x2013; review &#x0026; editing, Investigation. SC: Validation, Writing &#x2013; review &#x0026; editing. FW: Writing &#x2013; review &#x0026; editing. NW: Writing &#x2013; review &#x0026; editing. YC: Writing &#x2013; review &#x0026; editing. LQ: Writing &#x2013; review &#x0026; editing, Conceptualization, Funding acquisition, Supervision.</p>
</sec>
</body>
<back>
<sec sec-type="funding-information" id="sec34">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was funded by Guangdong Basic and Applied Basic Research Foundation (2021A1515012388) and the Guangdong Provincial Key Laboratory of Animal Molecular Design and Precise Breeding (2019B030301010).</p>
</sec>
<ack>
<p><xref ref-type="fig" rid="fig1">Figure 1</xref> was created with <ext-link xlink:href="https://www.biorender.com/" ext-link-type="uri">BioRender.com</ext-link>. The authors express our gratitude to the researchers for their valuable assistance throughout the trial.</p>
</ack>
<sec sec-type="COI-statement" id="sec35">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec100" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec36">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fvets.2024.1360878/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fvets.2024.1360878/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Teng</surname><given-names>M</given-names></name> <name><surname>Zheng</surname><given-names>L-P</given-names></name> <name><surname>Li</surname><given-names>H-Z</given-names></name> <name><surname>Ma</surname><given-names>S-M</given-names></name> <name><surname>Zhu</surname><given-names>Z-J</given-names></name> <name><surname>Chai</surname><given-names>S-J</given-names></name> <etal/></person-group>. <article-title>Pathogenicity and Pathotype analysis of Henan isolates of Marek&#x2019;s disease virus reveal long-term circulation of highly virulent MDV variant in China</article-title>. <source>Viruses</source>. (<year>2022</year>) <volume>14</volume>:<fpage>1651</fpage>. doi: <pub-id pub-id-type="doi">10.3390/v14081651</pub-id>, PMID: <pub-id pub-id-type="pmid">36016273</pub-id></citation></ref>
<ref id="ref2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>H</given-names></name> <name><surname>Zhang</surname><given-names>Y</given-names></name> <name><surname>Sun</surname><given-names>G</given-names></name> <name><surname>Bao</surname><given-names>K</given-names></name> <name><surname>Gao</surname><given-names>Y</given-names></name> <name><surname>Qi</surname><given-names>X</given-names></name> <etal/></person-group>. <article-title>Genetic evolution of Gallid herpesvirus 2 isolated in China</article-title>. <source>Infect Genet Evol</source>. (<year>2017</year>) <volume>51</volume>:<fpage>263</fpage>&#x2013;<lpage>74</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.meegid.2016.04.027</pub-id></citation></ref>
<ref id="ref3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yanamala</surname><given-names>P</given-names></name> <name><surname>Sreedevi</surname><given-names>B</given-names></name> <name><surname>Nagaram</surname><given-names>VK</given-names></name> <name><surname>Chintamaneni</surname><given-names>S</given-names></name></person-group>. <article-title>Isolation and molecular characterization of a virulent Marek&#x2019;s disease virus serotype-1from Andhra Pradesh, India</article-title>. <source>Vet Ital</source>. (<year>2021</year>) <volume>57</volume>:<fpage>29</fpage>&#x2013;<lpage>39</lpage>. doi: <pub-id pub-id-type="doi">10.12834/VetIt.2197.13279.1</pub-id>, PMID: <pub-id pub-id-type="pmid">34313096</pub-id></citation></ref>
<ref id="ref4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kannaki</surname><given-names>TR</given-names></name> <name><surname>Priyanka</surname><given-names>E</given-names></name> <name><surname>Nishitha</surname><given-names>Y</given-names></name> <name><surname>Krishna</surname><given-names>SV</given-names></name> <name><surname>Haunshi</surname><given-names>S</given-names></name> <name><surname>Subbiah</surname><given-names>M</given-names></name></person-group>. <article-title>Molecular detection and phylogenetic analysis of Marek&#x2019;s disease virus virulence-associated genes from vaccinated flocks in southern India reveals circulation of virulent MDV genotype</article-title>. <source>Transbound Emerg Dis</source>. (<year>2022</year>) <volume>69</volume>:<fpage>e244</fpage>&#x2013;<lpage>53</lpage>. doi: <pub-id pub-id-type="doi">10.1111/tbed.14289</pub-id>, PMID: <pub-id pub-id-type="pmid">34403565</pub-id></citation></ref>
<ref id="ref5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Demeke</surname><given-names>B</given-names></name> <name><surname>Jenberie</surname><given-names>S</given-names></name> <name><surname>Tesfaye</surname><given-names>B</given-names></name> <name><surname>Ayelet</surname><given-names>G</given-names></name> <name><surname>Yami</surname><given-names>M</given-names></name> <name><surname>Lamien</surname><given-names>CE</given-names></name> <etal/></person-group>. <article-title>Investigation of Marek&#x2019;s disease virus from chickens in Central Ethiopia</article-title>. <source>Trop Anim Health Prod</source>. (<year>2017</year>) <volume>49</volume>:<fpage>403</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11250-016-1208-1</pub-id>, PMID: <pub-id pub-id-type="pmid">27975190</pub-id></citation></ref>
<ref id="ref6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bulbula</surname><given-names>A</given-names></name> <name><surname>Borena</surname><given-names>B</given-names></name> <name><surname>Tadesse</surname><given-names>B</given-names></name> <name><surname>Aliy</surname><given-names>A</given-names></name> <name><surname>Negessu</surname><given-names>D</given-names></name></person-group>. <article-title>Isolation and molecular detection of Marek&#x2019;s disease virus from outbreak cases in chicken in South Western Ethiopia</article-title>. <source>Vet Med</source>. (<year>2022</year>) <volume>13</volume>:<fpage>265</fpage>&#x2013;<lpage>75</lpage>. doi: <pub-id pub-id-type="doi">10.2147/VMRR.S376795</pub-id></citation></ref>
<ref id="ref7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Birhan</surname><given-names>M</given-names></name> <name><surname>Berhane</surname><given-names>N</given-names></name> <name><surname>Bitew</surname><given-names>M</given-names></name> <name><surname>Gelaye</surname><given-names>E</given-names></name> <name><surname>Getachew</surname><given-names>B</given-names></name> <name><surname>Zemene</surname><given-names>A</given-names></name> <etal/></person-group>. <article-title>Sero-epidemiology of Marek&#x2019;s disease virus on local and exotic chickens in Northwest Ethiopia</article-title>. <source>J Worlds Poultry Res</source>. (<year>2021</year>) <volume>11</volume>:<fpage>53</fpage>&#x2013;<lpage>63</lpage>. doi: <pub-id pub-id-type="doi">10.36380/jwpr.2021.8</pub-id></citation></ref>
<ref id="ref8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Birhan</surname><given-names>M</given-names></name> <name><surname>Gelaye</surname><given-names>E</given-names></name> <name><surname>Ibrahim</surname><given-names>SM</given-names></name> <name><surname>Berhane</surname><given-names>N</given-names></name> <name><surname>Abayneh</surname><given-names>T</given-names></name> <name><surname>Getachew</surname><given-names>B</given-names></name> <etal/></person-group>. <article-title>Marek&#x2019;s disease in chicken farms from Northwest Ethiopia: gross pathology, virus isolation, and molecular characterization</article-title>. <source>Virol J</source>. (<year>2023</year>) <volume>20</volume>:<fpage>45</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12985-023-02003-4</pub-id>, PMID: <pub-id pub-id-type="pmid">36890573</pub-id></citation></ref>
<ref id="ref9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Osterrieder</surname><given-names>N</given-names></name> <name><surname>Kamil</surname><given-names>JP</given-names></name> <name><surname>Schumacher</surname><given-names>D</given-names></name> <name><surname>Tischer</surname><given-names>BK</given-names></name> <name><surname>Trapp</surname><given-names>S</given-names></name></person-group>. <article-title>Marek&#x2019;s disease virus: from miasma to model</article-title>. <source>Nat Rev Microbiol</source>. (<year>2006</year>) <volume>4</volume>:<fpage>283</fpage>&#x2013;<lpage>94</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrmicro1382</pub-id>, PMID: <pub-id pub-id-type="pmid">16541136</pub-id></citation></ref>
<ref id="ref10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baigent</surname><given-names>SJ</given-names></name> <name><surname>Davison</surname><given-names>TF</given-names></name></person-group>. <article-title>Development and composition of lymphoid lesions in the spleens of Marek&#x2019;s disease virus-infected chickens: association with virus spread and the pathogenesis of Marek&#x2019;s disease</article-title>. <source>Avian Pathol</source>. (<year>1999</year>) <volume>28</volume>:<fpage>287</fpage>&#x2013;<lpage>300</lpage>. doi: <pub-id pub-id-type="doi">10.1080/03079459994786</pub-id>, PMID: <pub-id pub-id-type="pmid">26915385</pub-id></citation></ref>
<ref id="ref11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nicoll</surname><given-names>MP</given-names></name> <name><surname>Proen&#x00E7;a</surname><given-names>JT</given-names></name> <name><surname>Efstathiou</surname><given-names>S</given-names></name></person-group>. <article-title>The molecular basis of herpes simplex virus latency</article-title>. <source>FEMS Microbiol Rev</source>. (<year>2012</year>) <volume>36</volume>:<fpage>684</fpage>&#x2013;<lpage>705</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1574-6976.2011.00320.x</pub-id>, PMID: <pub-id pub-id-type="pmid">22150699</pub-id></citation></ref>
<ref id="ref12"><label>12.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>S</given-names></name> <name><surname>Hegele</surname><given-names>RG</given-names></name> <name><surname>Hogg</surname><given-names>JC</given-names></name></person-group>. <article-title>Latent viral infections</article-title> In: Fratamico PM, Smith JL, Brogden KM, editors. <source>Sequelae and long-term consequences of infectious diseases</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>John Wiley &#x0026; Sons, Ltd</publisher-name> (<year>2009</year>), <fpage>339</fpage>&#x2013;<lpage>69</lpage>.</citation></ref>
<ref id="ref13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rasschaert</surname><given-names>P</given-names></name> <name><surname>Gennart</surname><given-names>I</given-names></name> <name><surname>Boumart</surname><given-names>I</given-names></name> <name><surname>Dambrine</surname><given-names>G</given-names></name> <name><surname>Muylkens</surname><given-names>B</given-names></name> <name><surname>Rasschaert</surname><given-names>D</given-names></name> <etal/></person-group>. <article-title>Specific transcriptional and post-transcriptional regulation of the major immediate early ICP4 gene of GaHV-2 during the lytic, latent and reactivation phases</article-title>. <source>J Gen Virol</source>. (<year>2018</year>) <volume>99</volume>:<fpage>355</fpage>&#x2013;<lpage>68</lpage>. doi: <pub-id pub-id-type="doi">10.1099/jgv.0.001007</pub-id>, PMID: <pub-id pub-id-type="pmid">29458534</pub-id></citation></ref>
<ref id="ref14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sacks</surname><given-names>WR</given-names></name> <name><surname>Greene</surname><given-names>C</given-names></name> <name><surname>Aschman</surname><given-names>D</given-names></name> <name><surname>Schaffer</surname><given-names>PA</given-names></name></person-group>. <article-title>Herpes simplex virus type 1 ICP27 is an essential regulatory protein</article-title>. <source>J Virol</source>. (<year>1985</year>) <volume>55</volume>:<fpage>796</fpage>&#x2013;<lpage>805</lpage>. doi: <pub-id pub-id-type="doi">10.1128/jvi.55.3.796-805.1985</pub-id>, PMID: <pub-id pub-id-type="pmid">2991596</pub-id></citation></ref>
<ref id="ref15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>YH</given-names></name></person-group>. <article-title>Apoptosis of U937 human leukemic cells by sodium butyrate is associated with inhibition of telomerase activity</article-title>. <source>Int J Oncol</source>. (<year>2006</year>) <volume>29</volume>:<fpage>1207</fpage>&#x2013;<lpage>13</lpage>. doi: <pub-id pub-id-type="doi">10.3892/ijo.29.5.1207</pub-id></citation></ref>
<ref id="ref16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Calabresse</surname><given-names>C</given-names></name> <name><surname>Venturini</surname><given-names>L</given-names></name> <name><surname>Ronco</surname><given-names>G</given-names></name> <name><surname>Villa</surname><given-names>P</given-names></name> <name><surname>Chomienne</surname><given-names>C</given-names></name> <name><surname>Belpomme</surname><given-names>D</given-names></name></person-group>. <article-title>Butyric acid and its monosaccharide ester induce apoptosis in the HL-60 cell line</article-title>. <source>Biochem Bioph Res Co</source>. (<year>1993</year>) <volume>195</volume>:<fpage>31</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1006/bbrc.1993.2005</pub-id>, PMID: <pub-id pub-id-type="pmid">8363611</pub-id></citation></ref>
<ref id="ref17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shuwen</surname><given-names>H</given-names></name> <name><surname>Yangyanqiu</surname><given-names>W</given-names></name> <name><surname>Jian</surname><given-names>C</given-names></name> <name><surname>Boyang</surname><given-names>H</given-names></name> <name><surname>Gong</surname><given-names>C</given-names></name> <name><surname>Jing</surname><given-names>Z</given-names></name></person-group>. <article-title>Synergistic effect of sodium butyrate and oxaliplatin on colorectal cancer</article-title>. <source>Transl Oncol</source>. (<year>2022</year>) <volume>27</volume>:<fpage>101598</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tranon.2022.101598</pub-id>, PMID: <pub-id pub-id-type="pmid">36512976</pub-id></citation></ref>
<ref id="ref18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bian</surname><given-names>Z</given-names></name> <name><surname>Sun</surname><given-names>X</given-names></name> <name><surname>Liu</surname><given-names>L</given-names></name> <name><surname>Qin</surname><given-names>Y</given-names></name> <name><surname>Zhang</surname><given-names>Q</given-names></name> <name><surname>Liu</surname><given-names>H</given-names></name> <etal/></person-group>. <article-title>Sodium butyrate induces CRC cell Ferroptosis via the CD44/SLC7A11 pathway and exhibits a synergistic therapeutic effect with Erastin</article-title>. <source>Cancers</source>. (<year>2023</year>) <volume>15</volume>:<fpage>423</fpage>. doi: <pub-id pub-id-type="doi">10.3390/cancers15020423</pub-id>, PMID: <pub-id pub-id-type="pmid">36672372</pub-id></citation></ref>
<ref id="ref19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klepinina</surname><given-names>L</given-names></name> <name><surname>Klepinin</surname><given-names>A</given-names></name> <name><surname>Truu</surname><given-names>L</given-names></name> <name><surname>Chekulayev</surname><given-names>V</given-names></name> <name><surname>Vija</surname><given-names>H</given-names></name> <name><surname>Kuus</surname><given-names>K</given-names></name> <etal/></person-group>. <article-title>Colon cancer cell differentiation by sodium butyrate modulates metabolic plasticity of Caco-2 cells via alteration of phosphotransfer network</article-title>. <source>PLoS One</source>. (<year>2021</year>) <volume>16</volume>:<fpage>e0245348</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0245348</pub-id>, PMID: <pub-id pub-id-type="pmid">33471801</pub-id></citation></ref>
<ref id="ref20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parada Venegas</surname><given-names>D</given-names></name> <name><surname>De La Fuente</surname><given-names>MK</given-names></name> <name><surname>Landskron</surname><given-names>G</given-names></name> <name><surname>Gonz&#x00E1;lez</surname><given-names>MJ</given-names></name> <name><surname>Quera</surname><given-names>R</given-names></name> <name><surname>Dijkstra</surname><given-names>G</given-names></name> <etal/></person-group>. <article-title>Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases</article-title>. <source>Front Immunol</source>. (<year>2019</year>) <volume>10</volume>:<fpage>277</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2019.00277</pub-id>, PMID: <pub-id pub-id-type="pmid">30915065</pub-id></citation></ref>
<ref id="ref21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yusuf</surname><given-names>F</given-names></name> <name><surname>Adewiah</surname><given-names>S</given-names></name> <name><surname>Syam</surname><given-names>AF</given-names></name> <name><surname>Fatchiyah</surname><given-names>F</given-names></name></person-group>. <article-title>Altered profile of gut microbiota and the level short chain fatty acids in colorectal cancer patients</article-title>. <source>J Phys Conf Ser</source>. (<year>2019</year>) <volume>1146</volume>:<fpage>012037</fpage>. doi: <pub-id pub-id-type="doi">10.1088/1742-6596/1146/1/012037</pub-id></citation></ref>
<ref id="ref22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Foglietta</surname><given-names>F</given-names></name> <name><surname>Serpe</surname><given-names>L</given-names></name> <name><surname>Canaparo</surname><given-names>R</given-names></name> <name><surname>Vivenza</surname><given-names>N</given-names></name> <name><surname>Riccio</surname><given-names>G</given-names></name> <name><surname>Imbalzano</surname><given-names>E</given-names></name> <etal/></person-group>. <article-title>Modulation of butyrate anticancer activity by solid lipid nanoparticle delivery: an in vitro investigation on human breast Cancer and leukemia cell lines</article-title>. <source>J Pharm Pharm Sci</source>. (<year>2014</year>) <volume>17</volume>:<fpage>231</fpage>&#x2013;<lpage>47</lpage>. doi: <pub-id pub-id-type="doi">10.18433/J3XP4R</pub-id>, PMID: <pub-id pub-id-type="pmid">24934552</pub-id></citation></ref>
<ref id="ref23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Geng</surname><given-names>H-W</given-names></name> <name><surname>Yin</surname><given-names>F-Y</given-names></name> <name><surname>Zhang</surname><given-names>Z-F</given-names></name> <name><surname>Gong</surname><given-names>X</given-names></name> <name><surname>Yang</surname><given-names>Y</given-names></name></person-group>. <article-title>Butyrate suppresses glucose metabolism of colorectal Cancer cells via GPR109a-AKT signaling pathway and enhances chemotherapy</article-title>. <source>Front Mol Biosci</source>. (<year>2021</year>) <volume>8</volume>:<fpage>634874</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmolb.2021.634874</pub-id>, PMID: <pub-id pub-id-type="pmid">33855046</pub-id></citation></ref>
<ref id="ref24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Encarna&#x00E7;&#x00E3;o</surname><given-names>JC</given-names></name> <name><surname>Pires</surname><given-names>AS</given-names></name> <name><surname>Amaral</surname><given-names>RA</given-names></name> <name><surname>Gon&#x00E7;alves</surname><given-names>TJ</given-names></name> <name><surname>Laranjo</surname><given-names>M</given-names></name> <name><surname>Casalta-Lopes</surname><given-names>JE</given-names></name> <etal/></person-group>. <article-title>Butyrate, a dietary fiber derivative that improves irinotecan effect in colon cancer cells</article-title>. <source>J Nutr Biochem</source>. (<year>2018</year>) <volume>56</volume>:<fpage>183</fpage>&#x2013;<lpage>92</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jnutbio.2018.02.018</pub-id>, PMID: <pub-id pub-id-type="pmid">29587241</pub-id></citation></ref>
<ref id="ref25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y-H</given-names></name> <name><surname>Park</surname><given-names>J-W</given-names></name> <name><surname>Lee</surname><given-names>J-Y</given-names></name> <name><surname>Kwon</surname><given-names>TK</given-names></name></person-group>. <article-title>Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells</article-title>. <source>Carcinogenesis</source>. (<year>2004</year>) <volume>25</volume>:<fpage>1813</fpage>&#x2013;<lpage>20</lpage>. doi: <pub-id pub-id-type="doi">10.1093/carcin/bgh188</pub-id>, PMID: <pub-id pub-id-type="pmid">15142888</pub-id></citation></ref>
<ref id="ref26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bortoluzzi</surname><given-names>C</given-names></name> <name><surname>Pedroso</surname><given-names>AA</given-names></name> <name><surname>Mallo</surname><given-names>JJ</given-names></name> <name><surname>Puyalto</surname><given-names>M</given-names></name> <name><surname>Kim</surname><given-names>WK</given-names></name> <name><surname>Applegate</surname><given-names>TJ</given-names></name></person-group>. <article-title>Sodium butyrate improved performance while modulating the cecal microbiota and regulating the expression of intestinal immune-related genes of broiler chickens</article-title>. <source>Poult Sci</source>. (<year>2017</year>) <volume>96</volume>:<fpage>3981</fpage>&#x2013;<lpage>93</lpage>. doi: <pub-id pub-id-type="doi">10.3382/ps/pex218</pub-id>, PMID: <pub-id pub-id-type="pmid">29050425</pub-id></citation></ref>
<ref id="ref27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>A</given-names></name> <name><surname>Bansal</surname><given-names>M</given-names></name> <name><surname>Liyanage</surname><given-names>R</given-names></name> <name><surname>Upadhyay</surname><given-names>A</given-names></name> <name><surname>Rath</surname><given-names>N</given-names></name> <name><surname>Donoghue</surname><given-names>A</given-names></name> <etal/></person-group>. <article-title>Sodium butyrate modulates chicken macrophage proteins essential for <italic>Salmonella Enteritidis</italic> invasion</article-title>. <source>PLoS One</source>. (<year>2021</year>) <volume>16</volume>:<fpage>e0250296</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0250296</pub-id>, PMID: <pub-id pub-id-type="pmid">33909627</pub-id></citation></ref>
<ref id="ref28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>A</given-names></name> <name><surname>Bansal</surname><given-names>M</given-names></name> <name><surname>Wagle</surname><given-names>B</given-names></name> <name><surname>Sun</surname><given-names>X</given-names></name> <name><surname>Rath</surname><given-names>N</given-names></name> <name><surname>Donoghue</surname><given-names>A</given-names></name> <etal/></person-group>. <article-title>Sodium butyrate reduces <italic>Salmonella Enteritidis</italic> infection of chicken enterocytes and expression of inflammatory host genes in vitro</article-title>. <source>Front Microbiol</source>. (<year>2020</year>) <volume>11</volume>:<fpage>553670</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2020.553670</pub-id>, PMID: <pub-id pub-id-type="pmid">33042060</pub-id></citation></ref>
<ref id="ref29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>N</given-names></name> <name><surname>Khandelwal</surname><given-names>N</given-names></name> <name><surname>Kumar</surname><given-names>R</given-names></name> <name><surname>Chander</surname><given-names>Y</given-names></name> <name><surname>Rawat</surname><given-names>KD</given-names></name> <name><surname>Chaubey</surname><given-names>KK</given-names></name> <etal/></person-group>. <article-title>Inhibitor of Sarco/endoplasmic reticulum calcium-ATPase impairs multiple steps of paramyxovirus replication</article-title>. <source>Front Microbiol</source>. (<year>2019</year>) <volume>10</volume>:<fpage>209</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2019.00209</pub-id>, PMID: <pub-id pub-id-type="pmid">30814986</pub-id></citation></ref>
<ref id="ref30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>R-F</given-names></name> <name><surname>Liu</surname><given-names>J-X</given-names></name> <name><surname>Yan</surname><given-names>Y-X</given-names></name> <name><surname>Wang</surname><given-names>L</given-names></name> <name><surname>Wang</surname><given-names>Z-Y</given-names></name></person-group>. <article-title>Selenium relieves oxidative stress, inflammation, and apoptosis within spleen of chicken exposed to mercuric chloride</article-title>. <source>Poult Sci</source>. (<year>2020</year>) <volume>99</volume>:<fpage>5430</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.psj.2020.08.031</pub-id>, PMID: <pub-id pub-id-type="pmid">33142460</pub-id></citation></ref>
<ref id="ref31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>DY</given-names></name> <name><surname>Kim</surname><given-names>W</given-names></name> <name><surname>Nam</surname><given-names>SM</given-names></name> <name><surname>Kim</surname><given-names>DW</given-names></name> <name><surname>Chung</surname><given-names>JY</given-names></name> <name><surname>Choi</surname><given-names>SY</given-names></name> <etal/></person-group>. <article-title>Synergistic effects of sodium butyrate, a histone deacetylase inhibitor, on increase of neurogenesis induced by pyridoxine and increase of neural proliferation in the mouse dentate gyrus</article-title>. <source>Neurochem Res</source>. (<year>2011</year>) <volume>36</volume>:<fpage>1850</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11064-011-0503-5</pub-id></citation></ref>
<ref id="ref32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>A</given-names></name> <name><surname>Morsy</surname><given-names>MA</given-names></name> <name><surname>Jacob</surname><given-names>S</given-names></name></person-group>. <article-title>Dose translation between laboratory animals and human in preclinical and clinical phases of drug development</article-title>. <source>Drug Dev Res</source>. (<year>2018</year>) <volume>79</volume>:<fpage>373</fpage>&#x2013;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ddr.21461</pub-id>, PMID: <pub-id pub-id-type="pmid">30343496</pub-id></citation></ref>
<ref id="ref33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ziyuan</surname><given-names>L</given-names></name> <name><surname>Yilei</surname><given-names>L</given-names></name> <name><surname>Weishen</surname><given-names>L</given-names></name> <name><surname>Jundan</surname><given-names>L</given-names></name> <name><surname>Wencai</surname><given-names>Q</given-names></name> <name><surname>Luping</surname><given-names>T</given-names></name> <etal/></person-group>. <article-title>Measurement of equivalent conversion factors for body surface area of chickens and other laboratory animals</article-title>. <source>Progr Vet Med</source>. (<year>2018</year>) <volume>39</volume>:<fpage>129</fpage>&#x2013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.16437/j.cnki.1007-5038.2018.06.031</pub-id></citation></ref>
<ref id="ref34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>C</given-names></name> <name><surname>Liang</surname><given-names>Z</given-names></name> <name><surname>Lin</surname><given-names>Q</given-names></name> <name><surname>Chen</surname><given-names>M</given-names></name> <name><surname>Chang</surname><given-names>C</given-names></name> <name><surname>Zhou</surname><given-names>J</given-names></name> <etal/></person-group>. <article-title>Pathology, viremia, apoptosis during MDV latency in vaccinated chickens</article-title>. <source>Virology</source>. (<year>2023</year>) <volume>579</volume>:<fpage>169</fpage>&#x2013;<lpage>77</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.virol.2023.01.003</pub-id>, PMID: <pub-id pub-id-type="pmid">36696868</pub-id></citation></ref>
<ref id="ref35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y-B</given-names></name> <name><surname>Li</surname><given-names>S-Y</given-names></name> <name><surname>Liu</surname><given-names>J-Y</given-names></name> <name><surname>Xue</surname><given-names>J-J</given-names></name> <name><surname>Xu</surname><given-names>J-F</given-names></name> <name><surname>Chen</surname><given-names>T</given-names></name> <etal/></person-group>. <article-title>Long non-coding RNA NRSN2-AS1 promotes ovarian cancer progression through targeting PTK2/&#x03B2;-catenin pathway</article-title>. <source>Cell Death Dis</source>. (<year>2023</year>) <volume>14</volume>:<fpage>696</fpage>&#x2013;<lpage>14</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41419-023-06214-z</pub-id>, PMID: <pub-id pub-id-type="pmid">37875515</pub-id></citation></ref>
<ref id="ref36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamidu</surname><given-names>JA</given-names></name> <name><surname>Rieger</surname><given-names>AM</given-names></name> <name><surname>Fasenko</surname><given-names>GM</given-names></name> <name><surname>Barreda</surname><given-names>DR</given-names></name></person-group>. <article-title>Dissociation of chicken blastoderm for examination of apoptosis and necrosis by flow cytometry</article-title>. <source>Poult Sci</source>. (<year>2010</year>) <volume>89</volume>:<fpage>901</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.3382/ps.2009-00552</pub-id>, PMID: <pub-id pub-id-type="pmid">20371841</pub-id></citation></ref>
<ref id="ref37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z</given-names></name> <name><surname>Zheng</surname><given-names>M</given-names></name> <name><surname>Zhang</surname><given-names>L</given-names></name> <name><surname>Gong</surname><given-names>X</given-names></name> <name><surname>Xi</surname><given-names>R</given-names></name> <name><surname>Cui</surname><given-names>X</given-names></name> <etal/></person-group>. <article-title>Dynamic expression of death receptor adapter proteins tradd and fadd in Eimeria tenella-induced host cell apoptosis</article-title>. <source>Poult Sci</source>. (<year>2017</year>) <volume>96</volume>:<fpage>1438</fpage>&#x2013;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.3382/ps/pew496</pub-id>, PMID: <pub-id pub-id-type="pmid">28204749</pub-id></citation></ref>
<ref id="ref38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Valiulien&#x0117;</surname><given-names>G</given-names></name> <name><surname>Vitkevi&#x010D;ien&#x0117;</surname><given-names>A</given-names></name> <name><surname>Skliut&#x0117;</surname><given-names>G</given-names></name> <name><surname>Borutinskait&#x0117;</surname><given-names>V</given-names></name> <name><surname>Navakauskien&#x0117;</surname><given-names>R</given-names></name></person-group>. <article-title>Pharmaceutical drug metformin and MCL1 inhibitor S63845 exhibit anticancer activity in myeloid leukemia cells via redox remodeling</article-title>. <source>Molecules</source>. (<year>2021</year>) <volume>26</volume>:<fpage>2303</fpage>. doi: <pub-id pub-id-type="doi">10.3390/molecules26082303</pub-id>, PMID: <pub-id pub-id-type="pmid">33921161</pub-id></citation></ref>
<ref id="ref39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>F</given-names></name> <name><surname>Shu</surname><given-names>G</given-names></name> <name><surname>Peng</surname><given-names>X</given-names></name> <name><surname>Fang</surname><given-names>J</given-names></name> <name><surname>Chen</surname><given-names>K</given-names></name> <name><surname>Cui</surname><given-names>H</given-names></name> <etal/></person-group>. <article-title>Protective effects of sodium selenite against aflatoxin B1-induced oxidative stress and apoptosis in broiler spleen</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2013</year>) <volume>10</volume>:<fpage>2834</fpage>&#x2013;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.3390/ijerph10072834</pub-id>, PMID: <pub-id pub-id-type="pmid">23839060</pub-id></citation></ref>
<ref id="ref40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z-Y</given-names></name> <name><surname>Yu</surname><given-names>Y</given-names></name> <name><surname>Liu</surname><given-names>Y</given-names></name> <name><surname>Ou</surname><given-names>C-B</given-names></name> <name><surname>Zhang</surname><given-names>Y-H</given-names></name> <name><surname>Liu</surname><given-names>T-Y</given-names></name> <etal/></person-group>. <article-title>Differential expression of pro-inflammatory and anti-inflammatory genes of layer chicken bursa after experimental infection with infectious bursal disease virus</article-title>. <source>Poult Sci</source>. (<year>2019</year>) <volume>98</volume>:<fpage>5307</fpage>&#x2013;<lpage>14</lpage>. doi: <pub-id pub-id-type="doi">10.3382/ps/pez312</pub-id>, PMID: <pub-id pub-id-type="pmid">31222288</pub-id></citation></ref>
<ref id="ref41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Borowicz</surname><given-names>S</given-names></name> <name><surname>Van Scoyk</surname><given-names>M</given-names></name> <name><surname>Avasarala</surname><given-names>S</given-names></name> <name><surname>Karuppusamy Rathinam</surname><given-names>MK</given-names></name> <name><surname>Tauler</surname><given-names>J</given-names></name> <name><surname>Bikkavilli</surname><given-names>RK</given-names></name> <etal/></person-group>. <article-title>The soft agar Colony formation assay</article-title>. <source>J Vis Exp</source>. (<year>2014</year>):<fpage>e51998</fpage>. doi: <pub-id pub-id-type="doi">10.3791/51998</pub-id>, PMID: <pub-id pub-id-type="pmid">25408172</pub-id></citation></ref>
<ref id="ref42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>X</given-names></name> <name><surname>Tian</surname><given-names>Y</given-names></name> <name><surname>Guan</surname><given-names>R</given-names></name> <name><surname>Gao</surname><given-names>W</given-names></name> <name><surname>Yang</surname><given-names>X</given-names></name> <name><surname>Zhou</surname><given-names>L</given-names></name> <etal/></person-group>. <article-title>Infectious bronchitis virus infection induces apoptosis during replication in chicken macrophage HD11 cells</article-title>. <source>Viruses</source>. (<year>2017</year>) <volume>9</volume>:<fpage>198</fpage>. doi: <pub-id pub-id-type="doi">10.3390/v9080198</pub-id>, PMID: <pub-id pub-id-type="pmid">28933760</pub-id></citation></ref>
<ref id="ref43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lockwood</surname><given-names>B</given-names></name> <name><surname>Bjerke</surname><given-names>S</given-names></name> <name><surname>Kobayashi</surname><given-names>K</given-names></name> <name><surname>Guo</surname><given-names>S</given-names></name></person-group>. <article-title>Acute effects of alcohol on larval zebrafish: a genetic system for large-scale screening</article-title>. <source>Pharmacol Biochem Behav</source>. (<year>2004</year>) <volume>77</volume>:<fpage>647</fpage>&#x2013;<lpage>54</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.pbb.2004.01.003</pub-id>, PMID: <pub-id pub-id-type="pmid">15006478</pub-id></citation></ref>
<ref id="ref44"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>M-X</given-names></name> <name><surname>Ma</surname><given-names>N</given-names></name> <name><surname>Li</surname><given-names>M-K</given-names></name> <name><surname>Liu</surname><given-names>Y-Y</given-names></name> <name><surname>Chen</surname><given-names>T</given-names></name> <name><surname>Wei</surname><given-names>F</given-names></name> <etal/></person-group>. <article-title>Antiviral properties of R. Tanguticum nanoparticles on herpes simplex virus type I in vitro and in vivo</article-title>. <source>Front Pharmacol</source>. (<year>2019</year>) <volume>10</volume>:<fpage>959</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphar.2019.00959</pub-id>, PMID: <pub-id pub-id-type="pmid">31555137</pub-id></citation></ref>
<ref id="ref45"><label>45.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cassidy-Stone</surname><given-names>A</given-names></name> <name><surname>Chipuk</surname><given-names>JE</given-names></name> <name><surname>Ingerman</surname><given-names>E</given-names></name> <name><surname>Song</surname><given-names>C</given-names></name> <name><surname>Yoo</surname><given-names>C</given-names></name> <name><surname>Kuwana</surname><given-names>T</given-names></name> <etal/></person-group>. <article-title>Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane Permeabilization</article-title>. <source>Dev Cell</source>. (<year>2008</year>) <volume>14</volume>:<fpage>193</fpage>&#x2013;<lpage>204</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.devcel.2007.11.019</pub-id>, PMID: <pub-id pub-id-type="pmid">18267088</pub-id></citation></ref>
<ref id="ref46"><label>46.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>IU</given-names></name> <name><surname>Schriml</surname><given-names>LM</given-names></name> <name><surname>Dean</surname><given-names>M</given-names></name></person-group>. <article-title>Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity</article-title>. <source>J Natl Cancer Inst</source>. (<year>1999</year>) <volume>91</volume>:<fpage>1922</fpage>&#x2013;<lpage>32</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jnci/91.22.1922</pub-id>, PMID: <pub-id pub-id-type="pmid">10564676</pub-id></citation></ref>
<ref id="ref47"><label>47.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Draheim</surname><given-names>KM</given-names></name> <name><surname>Chen</surname><given-names>H-B</given-names></name> <name><surname>Tao</surname><given-names>Q</given-names></name> <name><surname>Moore</surname><given-names>N</given-names></name> <name><surname>Roche</surname><given-names>M</given-names></name> <name><surname>Lyle</surname><given-names>S</given-names></name></person-group>. <article-title>ARRDC3 suppresses breast cancer progression by negatively regulating integrin &#x03B2;4</article-title>. <source>Oncogene</source>. (<year>2010</year>) <volume>29</volume>:<fpage>5032</fpage>&#x2013;<lpage>47</lpage>. doi: <pub-id pub-id-type="doi">10.1038/onc.2010.250</pub-id>, PMID: <pub-id pub-id-type="pmid">20603614</pub-id></citation></ref>
<ref id="ref48"><label>48.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meulmeester</surname><given-names>E</given-names></name> <name><surname>ten Dijke</surname><given-names>P</given-names></name></person-group>. <article-title>The dynamic roles of TGF-&#x03B2; in cancer</article-title>. <source>J Pathol</source>. (<year>2011</year>) <volume>223</volume>:<fpage>206</fpage>&#x2013;<lpage>19</lpage>. doi: <pub-id pub-id-type="doi">10.1002/path.2785</pub-id></citation></ref>
<ref id="ref49"><label>49.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gimeno</surname><given-names>I</given-names></name> <name><surname>Anderson</surname><given-names>A</given-names></name> <name><surname>Morgan</surname><given-names>RW</given-names></name> <name><surname>Silva</surname><given-names>RF</given-names></name> <name><surname>Witter</surname><given-names>RL</given-names></name> <name><surname>Kung</surname><given-names>H-J</given-names></name></person-group>. <article-title>Marek&#x2019;s disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication</article-title>. <source>Proc Natl Acad Sci</source>. (<year>2004</year>) <volume>101</volume>:<fpage>11815</fpage>&#x2013;<lpage>20</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0404508101</pub-id>, PMID: <pub-id pub-id-type="pmid">15289599</pub-id></citation></ref>
<ref id="ref50"><label>50.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leib</surname><given-names>DA</given-names></name> <name><surname>Bogard</surname><given-names>CL</given-names></name> <name><surname>Kosz-Vnenchak</surname><given-names>M</given-names></name> <name><surname>Hicks</surname><given-names>KA</given-names></name> <name><surname>Coen</surname><given-names>DM</given-names></name> <name><surname>Knipe</surname><given-names>DM</given-names></name> <etal/></person-group>. <article-title>A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency</article-title>. <source>J Virol</source>. (<year>1989</year>) <volume>63</volume>:<fpage>2893</fpage>&#x2013;<lpage>900</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JVI.63.7.2893-2900.1989</pub-id>, PMID: <pub-id pub-id-type="pmid">2542601</pub-id></citation></ref>
<ref id="ref51"><label>51.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abujoub</surname><given-names>AA</given-names></name> <name><surname>Coussens</surname><given-names>PM</given-names></name></person-group>. <article-title>Evidence that Marek&#x2019;s disease virus exists in a latent state in a sustainable fibroblast cell line</article-title>. <source>Virology</source>. (<year>1997</year>) <volume>229</volume>:<fpage>309</fpage>&#x2013;<lpage>21</lpage>. doi: <pub-id pub-id-type="doi">10.1006/viro.1997.8444</pub-id>, PMID: <pub-id pub-id-type="pmid">9126245</pub-id></citation></ref>
<ref id="ref52"><label>52.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Calnek</surname><given-names>BW</given-names></name> <name><surname>Witter</surname><given-names>RL</given-names></name></person-group>. <source>Diseases of poultry</source>. <publisher-loc>Ames, Iowa, USA</publisher-loc>: <publisher-name>Iowa State Univ. Press</publisher-name>. (<year>1997</year>), <fpage>342</fpage>&#x2013;<lpage>85</lpage>.</citation></ref>
<ref id="ref53"><label>53.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Silver</surname><given-names>S</given-names></name> <name><surname>Tanaka</surname><given-names>A</given-names></name> <name><surname>Nonoyama</surname><given-names>M</given-names></name></person-group>. <article-title>Transcription of the Marek&#x2019;s disease virus genome in a nonproductive chicken lymphoblastoid cell line</article-title>. <source>Virology</source>. (<year>1979</year>) <volume>93</volume>:<fpage>127</fpage>&#x2013;<lpage>33</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0042-6822(79)90281-2</pub-id>, PMID: <pub-id pub-id-type="pmid">219594</pub-id></citation></ref>
<ref id="ref54"><label>54.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mwangi</surname><given-names>WN</given-names></name> <name><surname>Vasoya</surname><given-names>D</given-names></name> <name><surname>Kgosana</surname><given-names>LB</given-names></name> <name><surname>Watson</surname><given-names>M</given-names></name> <name><surname>Nair</surname><given-names>V</given-names></name></person-group>. <article-title>Differentially expressed genes during spontaneous lytic switch of Marek&#x2019;s disease virus in lymphoblastoid cell lines determined by global gene expression profiling</article-title>. <source>J Gen Virol</source>. (<year>2017</year>) <volume>98</volume>:<fpage>779</fpage>&#x2013;<lpage>90</lpage>. doi: <pub-id pub-id-type="doi">10.1099/jgv.0.000744</pub-id>, PMID: <pub-id pub-id-type="pmid">28475033</pub-id></citation></ref>
<ref id="ref55"><label>55.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shek</surname><given-names>WR</given-names></name> <name><surname>Calnek</surname><given-names>BW</given-names></name> <name><surname>Schat</surname><given-names>KA</given-names></name> <name><surname>Chen</surname><given-names>CH</given-names></name></person-group>. <article-title>Characterization of Marek&#x2019;s disease virus-infected lymphocytes: discrimination between cytolytically and latently infected cells</article-title>. <source>J Natl Cancer Inst</source>. (<year>1983</year>) <volume>70</volume>:<fpage>485</fpage>&#x2013;<lpage>91</lpage>. PMID: <pub-id pub-id-type="pmid">6300499</pub-id></citation></ref>
<ref id="ref56"><label>56.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fulda</surname><given-names>S</given-names></name> <name><surname>Debatin</surname><given-names>K-M</given-names></name></person-group>. <article-title>Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy</article-title>. <source>Oncogene</source>. (<year>2006</year>) <volume>25</volume>:<fpage>4798</fpage>&#x2013;<lpage>811</lpage>. doi: <pub-id pub-id-type="doi">10.1038/sj.onc.1209608</pub-id>, PMID: <pub-id pub-id-type="pmid">16892092</pub-id></citation></ref>
<ref id="ref57"><label>57.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roca-Agujetas</surname><given-names>V</given-names></name> <name><surname>De Dios</surname><given-names>C</given-names></name> <name><surname>Lest&#x00F3;n</surname><given-names>L</given-names></name> <name><surname>Mar&#x00ED;</surname><given-names>M</given-names></name> <name><surname>Morales</surname><given-names>A</given-names></name> <name><surname>Colell</surname><given-names>A</given-names></name></person-group>. <article-title>Recent insights into the mitochondrial role in autophagy and its regulation by oxidative stress</article-title>. <source>Oxidative Med Cell Longev</source>. (<year>2019</year>) <volume>2019</volume>:<fpage>1</fpage>&#x2013;<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.1155/2019/3809308</pub-id>, PMID: <pub-id pub-id-type="pmid">31781334</pub-id></citation></ref>
<ref id="ref58"><label>58.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mu</surname><given-names>D</given-names></name> <name><surname>Gao</surname><given-names>Z</given-names></name> <name><surname>Guo</surname><given-names>H</given-names></name> <name><surname>Zhou</surname><given-names>G</given-names></name> <name><surname>Sun</surname><given-names>B</given-names></name></person-group>. <article-title>Sodium butyrate induces growth inhibition and apoptosis in human prostate Cancer DU145 cells by up-regulation of the expression of Annexin A1</article-title>. <source>PLoS One</source>. (<year>2013</year>) <volume>8</volume>:<fpage>e74922</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0074922</pub-id>, PMID: <pub-id pub-id-type="pmid">24086397</pub-id></citation></ref>
<ref id="ref59"><label>59.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>X</given-names></name> <name><surname>Xu</surname><given-names>Y</given-names></name> <name><surname>Chen</surname><given-names>H</given-names></name></person-group>. <article-title>Sodium butyrate-activated TRAF6-TXNIP pathway affects A549 cells proliferation and migration</article-title>. <source>Cancer Med</source>. (<year>2020</year>) <volume>9</volume>:<fpage>3477</fpage>&#x2013;<lpage>88</lpage>. doi: <pub-id pub-id-type="doi">10.1002/cam4.2564</pub-id>, PMID: <pub-id pub-id-type="pmid">31578830</pub-id></citation></ref>
<ref id="ref60"><label>60.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name> <name><surname>He</surname><given-names>P</given-names></name> <name><surname>Liu</surname><given-names>Y</given-names></name> <name><surname>Qi</surname><given-names>M</given-names></name> <name><surname>Dong</surname><given-names>W</given-names></name></person-group>. <article-title>Combining sodium butyrate with cisplatin increases the apoptosis of gastric Cancer in vivo and in vitro via the mitochondrial apoptosis pathway</article-title>. <source>Front Pharmacol</source>. (<year>2021</year>) <volume>12</volume>:<fpage>708093</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphar.2021.708093</pub-id>, PMID: <pub-id pub-id-type="pmid">34512341</pub-id></citation></ref>
<ref id="ref61"><label>61.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lossi</surname><given-names>L</given-names></name></person-group>. <article-title>The concept of intrinsic versus extrinsic apoptosis</article-title>. <source>Biochem J</source>. (<year>2022</year>) <volume>479</volume>:<fpage>357</fpage>&#x2013;<lpage>84</lpage>. doi: <pub-id pub-id-type="doi">10.1042/BCJ20210854</pub-id>, PMID: <pub-id pub-id-type="pmid">35147165</pub-id></citation></ref>
<ref id="ref62"><label>62.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fulda</surname><given-names>S</given-names></name> <name><surname>Galluzzi</surname><given-names>L</given-names></name> <name><surname>Kroemer</surname><given-names>G</given-names></name></person-group>. <article-title>Targeting mitochondria for cancer therapy</article-title>. <source>Nat Rev Drug Discov</source>. (<year>2010</year>) <volume>9</volume>:<fpage>447</fpage>&#x2013;<lpage>64</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrd3137</pub-id></citation></ref>
<ref id="ref63"><label>63.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>M</given-names></name> <name><surname>Li</surname><given-names>M</given-names></name> <name><surname>Wang</surname><given-names>W</given-names></name> <name><surname>Deng</surname><given-names>Q</given-names></name> <name><surname>Li</surname><given-names>Q</given-names></name> <name><surname>Gao</surname><given-names>Y</given-names></name> <etal/></person-group>. <article-title>The emergence of a vv + MDV can break through the protections provided by the current vaccines</article-title>. <source>Viruses</source>. (<year>2020</year>) <volume>12</volume>:<fpage>1048</fpage>. doi: <pub-id pub-id-type="doi">10.3390/v12091048</pub-id>, PMID: <pub-id pub-id-type="pmid">32962247</pub-id></citation></ref>
<ref id="ref64"><label>64.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name> <name><surname>Ge</surname><given-names>Z</given-names></name> <name><surname>Luo</surname><given-names>Q</given-names></name> <name><surname>Fu</surname><given-names>Q</given-names></name> <name><surname>Chen</surname><given-names>R</given-names></name></person-group>. <article-title>A highly pathogenic Marek&#x2019;s disease virus isolate from chickens immunized with a bivalent vaccine in China</article-title>. <source>Arch Virol</source>. (<year>2022</year>) <volume>167</volume>:<fpage>861</fpage>&#x2013;<lpage>70</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00705-021-05355-w</pub-id>, PMID: <pub-id pub-id-type="pmid">35129660</pub-id></citation></ref>
<ref id="ref65"><label>65.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>L</given-names></name> <name><surname>Li</surname><given-names>J</given-names></name> <name><surname>Peng</surname><given-names>P</given-names></name> <name><surname>Nie</surname><given-names>J</given-names></name> <name><surname>Luo</surname><given-names>J</given-names></name> <name><surname>Cao</surname><given-names>Y</given-names></name> <etal/></person-group>. <article-title>Genomic analysis of a Chinese MDV strain derived from vaccine strain CVI988 through recombination</article-title>. <source>Infect Genet Evol</source>. (<year>2020</year>) <volume>78</volume>:<fpage>104045</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.meegid.2019.104045</pub-id>, PMID: <pub-id pub-id-type="pmid">31698116</pub-id></citation></ref>
</ref-list>
</back>
</article>